Matches in SemOpenAlex for { <https://semopenalex.org/work/W2796965324> ?p ?o ?g. }
- W2796965324 endingPage "85" @default.
- W2796965324 startingPage "75" @default.
- W2796965324 abstract "Adalimumab (ADA) is a tumor necrosis factor (TNF)-alpha inhibitor indicated for the treatment of inflammatory autoimmune diseases, including ankylosing spondylitis (AS). Patients receiving ADA in Canada are eligible to enroll in the AbbVie Care™ patient support program (AC-PSP), which provides personalized services, including care coach calls (CCCs). We estimated the likelihood of controlled disease in a cohort of AS patients treated with ADA enrolled in the AC-PSP and who received CCCs versus those who did not.A longitudinal analysis using de-identified aggregate-level data collected through the AC-PSP was performed. A probabilistic matching algorithm was used to link patient-level records from the AC-PSP database to records from the QuintilesIMS longitudinal prescription transactions database. Patients were indexed on the date of their first prescription of ADA between January 2010 and October 2015. The AC-PSP database included patient assessments of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), a measure of disease activity. Eligible patients had a baseline BASDAI assessment performed between 90 days before and 30 days after the index date, and a follow-up BASDAI assessment 6-18 months later. Poisson regression was used to estimate the adjusted relative risk (RR) of controlled disease (BASDAI < 4) at the time of follow-up, comparing patients who received CCCs with those who did not.In total 249 AS patients met eligibility criteria, and 123 (49%) received CCCs. Of the 249 patients, 184 (74%) had controlled disease (BASDAI < 4) at follow-up assessment, 98 (80%) in the CCC group and 86 (68%) in the no CCC group. Multivariable regression analysis demonstrated a 23% increased likelihood of controlled disease in patients who received CCCs relative to those who did not (RR = 1.23; 95% confidence interval, 1.06-1.42; p = 0.0055).AS patients receiving tailored services through the AC-PSP in the form of CCCs have an increased likelihood of controlled disease within 6-18 months.AbbVie." @default.
- W2796965324 created "2018-04-24" @default.
- W2796965324 creator A5011642018 @default.
- W2796965324 creator A5020515212 @default.
- W2796965324 creator A5022252385 @default.
- W2796965324 creator A5022840595 @default.
- W2796965324 creator A5032283613 @default.
- W2796965324 creator A5037341197 @default.
- W2796965324 creator A5054685224 @default.
- W2796965324 creator A5071663083 @default.
- W2796965324 creator A5072949655 @default.
- W2796965324 creator A5079946212 @default.
- W2796965324 creator A5087787202 @default.
- W2796965324 date "2018-04-09" @default.
- W2796965324 modified "2023-10-12" @default.
- W2796965324 title "Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study" @default.
- W2796965324 cites W1565102150 @default.
- W2796965324 cites W162418614 @default.
- W2796965324 cites W1757837840 @default.
- W2796965324 cites W1858946267 @default.
- W2796965324 cites W2024717312 @default.
- W2796965324 cites W2032261234 @default.
- W2796965324 cites W2063503125 @default.
- W2796965324 cites W2078651157 @default.
- W2796965324 cites W2097486992 @default.
- W2796965324 cites W2101141197 @default.
- W2796965324 cites W2103778140 @default.
- W2796965324 cites W2111505151 @default.
- W2796965324 cites W2114793173 @default.
- W2796965324 cites W2118293986 @default.
- W2796965324 cites W2160367898 @default.
- W2796965324 cites W2168251113 @default.
- W2796965324 cites W2344906617 @default.
- W2796965324 cites W2406423533 @default.
- W2796965324 cites W2572897530 @default.
- W2796965324 cites W2587612082 @default.
- W2796965324 cites W2600578385 @default.
- W2796965324 cites W2600684215 @default.
- W2796965324 cites W2792610153 @default.
- W2796965324 cites W3046652687 @default.
- W2796965324 doi "https://doi.org/10.1007/s40744-018-0109-3" @default.
- W2796965324 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5935622" @default.
- W2796965324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29633196" @default.
- W2796965324 hasPublicationYear "2018" @default.
- W2796965324 type Work @default.
- W2796965324 sameAs 2796965324 @default.
- W2796965324 citedByCount "7" @default.
- W2796965324 countsByYear W27969653242018 @default.
- W2796965324 countsByYear W27969653242019 @default.
- W2796965324 countsByYear W27969653242020 @default.
- W2796965324 countsByYear W27969653242021 @default.
- W2796965324 countsByYear W27969653242022 @default.
- W2796965324 countsByYear W27969653242023 @default.
- W2796965324 crossrefType "journal-article" @default.
- W2796965324 hasAuthorship W2796965324A5011642018 @default.
- W2796965324 hasAuthorship W2796965324A5020515212 @default.
- W2796965324 hasAuthorship W2796965324A5022252385 @default.
- W2796965324 hasAuthorship W2796965324A5022840595 @default.
- W2796965324 hasAuthorship W2796965324A5032283613 @default.
- W2796965324 hasAuthorship W2796965324A5037341197 @default.
- W2796965324 hasAuthorship W2796965324A5054685224 @default.
- W2796965324 hasAuthorship W2796965324A5071663083 @default.
- W2796965324 hasAuthorship W2796965324A5072949655 @default.
- W2796965324 hasAuthorship W2796965324A5079946212 @default.
- W2796965324 hasAuthorship W2796965324A5087787202 @default.
- W2796965324 hasBestOaLocation W27969653241 @default.
- W2796965324 hasConcept C126322002 @default.
- W2796965324 hasConcept C1862650 @default.
- W2796965324 hasConcept C2426938 @default.
- W2796965324 hasConcept C2776260265 @default.
- W2796965324 hasConcept C2777402515 @default.
- W2796965324 hasConcept C2777453003 @default.
- W2796965324 hasConcept C2779134260 @default.
- W2796965324 hasConcept C2780132546 @default.
- W2796965324 hasConcept C71924100 @default.
- W2796965324 hasConcept C72563966 @default.
- W2796965324 hasConcept C98274493 @default.
- W2796965324 hasConceptScore W2796965324C126322002 @default.
- W2796965324 hasConceptScore W2796965324C1862650 @default.
- W2796965324 hasConceptScore W2796965324C2426938 @default.
- W2796965324 hasConceptScore W2796965324C2776260265 @default.
- W2796965324 hasConceptScore W2796965324C2777402515 @default.
- W2796965324 hasConceptScore W2796965324C2777453003 @default.
- W2796965324 hasConceptScore W2796965324C2779134260 @default.
- W2796965324 hasConceptScore W2796965324C2780132546 @default.
- W2796965324 hasConceptScore W2796965324C71924100 @default.
- W2796965324 hasConceptScore W2796965324C72563966 @default.
- W2796965324 hasConceptScore W2796965324C98274493 @default.
- W2796965324 hasIssue "1" @default.
- W2796965324 hasLocation W27969653241 @default.
- W2796965324 hasLocation W27969653242 @default.
- W2796965324 hasLocation W27969653243 @default.
- W2796965324 hasLocation W27969653244 @default.
- W2796965324 hasOpenAccess W2796965324 @default.
- W2796965324 hasPrimaryLocation W27969653241 @default.
- W2796965324 hasRelatedWork W2052900499 @default.
- W2796965324 hasRelatedWork W2094784390 @default.
- W2796965324 hasRelatedWork W2112098332 @default.